sponsored
PatientsVille.com Logo

PatientsVille

Metronidazole and Ritalin

Compare Side Effects

% of total side effects reported by users. DISCLAIMER: ALL DATA PROVIDED AS-IS. Data Source: openfda.gov.
Side EffectMetronidazoleRitalin
DRUG INEFFECTIVE2.7% 4.4%
DIARRHOEA3.5% 1.3%
NAUSEA3.4% 3%
FATIGUE1.9% 3.4%
HEADACHE2.2% 2.8%
DEPRESSION1% 2.8%
ANXIETY1.4% 2.7%
VOMITING2.5% 1.6%
PYREXIA2.5% 0.9%
PAIN2.2% 1.6%
DIZZINESS2.1% 1.9%
FEELING ABNORMAL0.6% 2.1%
INSOMNIA0.9% 2%
SOMNOLENCE0.7% 2%
DYSPNOEA1.9% 1.4%
WEIGHT DECREASED0.9% 1.8%
ABDOMINAL PAIN1.8% 0.7%
FALL0.8% 1.6%
RASH1.6% 0.8%
DRUG INTERACTION1.6% 0.7%
MALAISE1.5% 1.5%
ASTHENIA1.5% 1.3%
OFF LABEL USE1% 1.4%
DECREASED APPETITE0.9% 1.4%
HYPERTENSION0.8% 1.4%
DRUG HYPERSENSITIVITY1.4% 0.5%
SUICIDAL IDEATION0% 1.4%
CONFUSIONAL STATE1.3% 1%
CONDITION AGGRAVATED1% 1.3%
TREMOR0.7% 1.3%
PRURITUS1.3% 0.6%
AGITATION0% 1.3%
DISTURBANCE IN ATTENTION0% 1.3%
WEIGHT INCREASED0% 1.3%
ANAEMIA1.3% 0%
AGGRESSION0% 1.3%
HYPOTENSION1.3% 0%
PNEUMONIA1.2% 0.7%
SEPSIS1.2% 0%
PAIN IN EXTREMITY1.1% 0.9%
ARTHRALGIA1.1% 0.9%
PARAESTHESIA1.1% 0.7%
RENAL FAILURE1.1% 0%
CLOSTRIDIUM DIFFICILE INFECTION1.1% 0%
ABNORMAL BEHAVIOUR0% 1.1%
ACUTE KIDNEY INJURY1.1% 0%
ABDOMINAL PAIN UPPER1% 0.7%
PATHOGEN RESISTANCE1% 0%
CHEST PAIN0.8% 0.9%
DEATH0.9% 0.7%
TACHYCARDIA0.7% 0.9%
MEMORY IMPAIRMENT0% 0.9%
DRUG DOSE OMISSION0% 0.9%
BLOOD PRESSURE INCREASED0% 0.9%
SEPTIC SHOCK0.9% 0%
GAIT DISTURBANCE0.8% 0.8%
BACK PAIN0.8% 0.8%
HYPERSENSITIVITY0.8% 0.7%
MUSCLE SPASMS0.7% 0.8%
TOXICITY TO VARIOUS AGENTS0.8% 0.6%
DEHYDRATION0.8% 0.6%
URINARY TRACT INFECTION0.8% 0.5%
TOXIC ENCEPHALOPATHY0.8% 0%
CLOSTRIDIUM DIFFICILE COLITIS0.8% 0%
INJURY0.8% 0%
THROMBOCYTOPENIA0.8% 0%
PULMONARY EMBOLISM0.8% 0%
UNEVALUABLE EVENT0% 0.8%
ERYTHEMA0.8% 0%
IRRITABILITY0% 0.8%
HYPERHIDROSIS0% 0.8%
THERAPEUTIC RESPONSE UNEXPECTED0% 0.8%
NEUTROPENIA0.8% 0%
NEUROPATHY PERIPHERAL0.8% 0%
HYPOAESTHESIA0.7% 0.7%
CONSTIPATION0.6% 0.7%
COUGH0.6% 0.7%
PALPITATIONS0.5% 0.7%
INFECTION0.7% 0%
URTICARIA0.7% 0%
GENERAL PHYSICAL HEALTH DETERIORATION0.7% 0%
HAEMORRHAGE0.7% 0%
RESPIRATORY FAILURE0.7% 0%
ANAPHYLACTIC REACTION0.7% 0%
DYSGEUSIA0.7% 0%
DEEP VEIN THROMBOSIS0.7% 0%
DYSPHAGIA0.7% 0%
DRUG DEPENDENCE0% 0.7%
ALANINE AMINOTRANSFERASE INCREASED0.7% 0%
SLEEP APNOEA SYNDROME0% 0.7%
DRUG ABUSE0% 0.7%
PRE-EXISTING CONDITION IMPROVED0% 0.7%
NASOPHARYNGITIS0% 0.7%
OVERDOSE0% 0.7%
SUICIDE ATTEMPT0% 0.7%
MIGRAINE0% 0.7%
HEART RATE INCREASED0% 0.7%
LOSS OF CONSCIOUSNESS0% 0.7%
HALLUCINATION0% 0.7%
CHRONIC KIDNEY DISEASE0.7% 0%
DYSARTHRIA0.7% 0%
MUSCULAR WEAKNESS0.6% 0.5%
MYALGIA0.6% 0%
CONVULSION0% 0.6%
STRESS0% 0.6%
PRODUCT USE ISSUE0% 0.6%
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS0% 0.6%
RENAL FAILURE ACUTE0.6% 0%
OEDEMA PERIPHERAL0.6% 0%
ENCEPHALOPATHY0.6% 0%
HAEMOGLOBIN DECREASED0.6% 0%
PANCYTOPENIA0.6% 0%
ABDOMINAL DISTENSION0.6% 0%
NEUROTOXICITY0.6% 0%
VISION BLURRED0% 0.6%
INTERNATIONAL NORMALISED RATIO INCREASED0.6% 0%
EXPOSURE DURING PREGNANCY0.6% 0%
ATRIAL FIBRILLATION0.6% 0%
ABDOMINAL DISCOMFORT0.5% 0.5%
SLEEP DISORDER0% 0.5%
ANGER0% 0.5%
INTENTIONAL PRODUCT USE ISSUE0% 0.5%
PSYCHOMOTOR HYPERACTIVITY0% 0.5%
CRYING0% 0.5%
NERVOUSNESS0% 0.5%
SEIZURE0% 0.5%
DYSKINESIA0% 0.5%
BALANCE DISORDER0% 0.5%
DRUG WITHDRAWAL SYNDROME0% 0.5%
DRY MOUTH0% 0.5%
AMNESIA0% 0.5%
PSYCHOTIC DISORDER0% 0.5%
ALOPECIA0% 0.5%
DEPRESSED MOOD0% 0.5%
SINUSITIS0% 0.5%
DRUG EFFECT DECREASED0% 0.5%
ATAXIA0.5% 0%
OEDEMA0.5% 0%
PLEURAL EFFUSION0.5% 0%
HEPATITIS0.5% 0%
COLITIS0.5% 0%
SWELLING FACE0.5% 0%
EMOTIONAL DISTRESS0.5% 0%
ASPARTATE AMINOTRANSFERASE INCREASED0.5% 0%
CHILLS0.5% 0%
CARDIAC ARREST0.5% 0%
INCORRECT DOSE ADMINISTERED0% 0.4%
PRODUCT QUALITY ISSUE0% 0.4%
RESTLESSNESS0% 0.4%

New treatments are found every day. View current Metronidazole research studies and Ritalin clinical trials

1